Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Mar. 30, 2012 Successor	Apr. 01, 2011 Predecessor
Cash flows from operating activities:
Net loss	$ (61,893)	$ (28,497)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	1,914	1,306
Amortization of intangible assets	4,053	568
Reversal of provision for bad debts, net	(10)
Charges for inventory provisions, net	306	458
Release of inventory step-up upon shipment	614
Amortization of debt (premium) discount	(2,322)	402
Asset impairments	54,869
Deferred income taxes	(6,254)	(20)
Stock-based compensation		3,712
Decrease in fair value of derivative instruments	928	5,779
Loss (gain) on equity method investments	356	(1,495)
Loss on escrow funds receivable	57
Net gain on sale of equity securities		(1,393)
Gain on sale of intellectual property		(1,249)
Other items, net	(22)	(301)
Changes in assets and liabilities:
Receivables	4,830	5,051
Inventories	5,187	(111)
Accounts payable	449	(461)
Accrued expenses and other current liabilities	(10,656)	(4,700)
Other, net	(6,203)	1,013
Net cash used in operating activities	(13,797)	(19,938)
Cash flows from investing activities:
Purchases of property, plant and equipment	(115)	(751)
Proceeds from sale of real estate, net of closing costs of $439		21,087
Proceeds from sale of property, plant and equipment		52
Proceeds from maturity of marketable securities		20,000
Proceeds from sales of equity securities		802
Restricted cash	174	70
Proceeds from sale of intellectual property		1,249
Net cash provided by investing activities	59	42,509
Cash flows from financing activities:
Net repayments of short-term debt		(11,278)
Proceeds from issuance of common stock under employee stock plans		94
Employee income tax paid related to vesting of restricted stock units		(681)
Net cash used in financing activities		(11,865)
Net (decrease) increase in cash and cash equivalents	(13,738)	10,706
Cash and cash equivalents at beginning of period	38,056	54,466
Cash and cash equivalents at end of period	$ 24,318	$ 65,172